Nabil Sifo
๐๐จ๐ซ๐ญ๐Ÿ๐จ๐ฅ๐ข๐จ ๐ฎ๐ฉ๐๐š๐ญ๐ž: ๐•๐จ๐ฅ๐š๐ญ๐ข๐ฅ๐ž ๐ฌ๐ญ๐š๐ซ๐ญ ๐ข๐ง ๐’๐ž๐ฉ๐ญ๐ž๐ฆ๐›๐ž๐ซ Dear Copiers and followers, The first week of September was very volatile, living up to the reputation of September. Not every day was red though, and our portfolio is still holding in the green still, thanks to the broad diversification across different uncorrelated sectors. The worst performance across our portfolio was the semiconductor stocks, which I believe is a temporary pullback. ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ž: Last week the US job data was released with the number of jobs added at 22,000 in August, which is dramatically lower than economistsโ€™ expectations of 76,500 jobs! This implies that the economy lost jobs (in total) and the unemployment level rose to 4.3%, the highest level since 2021. The reason for this shrinkage in job offerings, in my opinion, is related to the tariffs impact on the cost of manufacturing and probably the new stricter immigration rules, which reduce the amount of cheap available labor, especially in manufacturing. ๐–๐ก๐ฒ ๐š๐ซ๐ž ๐ฃ๐จ๐› ๐๐š๐ญ๐š ๐ข๐ฆ๐ฉ๐จ๐ซ๐ญ๐š๐ง๐ญ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž ๐ฌ๐ญ๐จ๐œ๐ค ๐ฆ๐š๐ซ๐ค๐ž๐ญ? Job data are one of the most important indicators of economic growth. This data reflects the impact of new policies and inflation on the economic. When job data show signs of economic weakening, the Federal Reserve suffers more pressure to react and reduce the interest rate. Reducing (cutting) the interest rate means cheaper money to borrow for companies. The lower interest rate also puts growth stocks, which are not profitable yet, in a better position, and mostly the stock market rises when the interest rate falls. ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ๐š๐ง๐ญ: One month is not enough data to draw conclusions, but enough to get alerted. Use this info with caution because mapping the relation between the economy and the stock market is way more complicated than one straightforward correlation. ๐๐จ๐ซ๐ญ๐Ÿ๐จ๐ฅ๐ข๐จ ๐”๐ฉ๐๐š๐ญ๐ž: Last week was really a mixed performance for the stocks in our portfolio. While the semiconductor stocks dragged the portfolio down, our latest addition to the portfolio performed exceptionally well. Chinese exposure moved higher, and both $IOT (Samsara Inc) and $OSCR (Oscar Health Inc) had strong runs. Another great run last week was $HIMS (Hims & Hers Health Inc) stock, which moved almost 14%. This rebound in HIMS stock came after a U.S. District Judge threw out Eli Lillyโ€™s case against Willow, a telehealth provider offering compounded formulations of Lillyโ€™s GLP 1 drugs. This reduced the risk of a potential lawsuit against HIMS based on the $NVO (Novo-Nordisk A/S SPONS ADR) claims of mass compounding. Last week there were no changes in our portfolio, and I am planning not to change much in the portfolio this month. We hit a new lower risk score of max 4. This is even very low for my risk appetite, but shows good resilience against potential volatility in September. Best regards, Nabil Sifo $SPX500 $NSDQ100 ________________________________________________________________________ I am a professional risk modeler and an Associate Member of the Chartered Institute for Securities & Investment (CISI), London. All posts reflect my personal opinions only and do not constitute, nor should they be interpreted as, financial advice or a recommendation to buy or sell any securities. ๐‘๐ข๐ฌ๐ค ๐–๐š๐ซ๐ง๐ข๐ง๐ ๐ฌ: Copy Trading does not amount to investment advice | Your capital is at risk | Past performance is not indicative of future results.
1 reply
2 replies
null
.